# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of ...
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...
Monetization of legacy asset brings in $3 million in nondilutive capital Convertible notes exchange brings in another $2.8 mill...
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.